Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Cimetidine in Advanced Blood-Brain Barrier and Cancer Resear
2026-08-05
Explore how Cimetidine, a histamine-2 receptor antagonist, is reshaping blood-brain barrier studies and gastrointestinal cancer research. This article uncovers new insights and protocols for leveraging Cimetidine’s unique pharmacology in translational assays.
-
TaqI Restriction Endonuclease: Fast DNA Digestion Workflows
2026-08-05
TaqI Restriction Endonuclease (SKU K3053) enables rapid, sequence-specific digestion of plasmid, PCR, or genomic DNA for molecular biology workflows demanding fast turnaround. It is optimized for research use and not intended for diagnostic or clinical applications.
-
Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In
2026-08-04
Wang et al. (2018) systematically dissected the entry pathway of type III grass carp reovirus (GCRV104), establishing that clathrin-mediated, pH-dependent endocytosis is crucial for viral uptake in host cells. The study leverages specific pharmacological inhibitors, including wortmannin, to clarify the distinct molecular mechanisms mediating viral entry, offering a foundation for antiviral strategy development.
-
Camptothecin: Topoisomerase I Inhibitor for DNA Damage Assay
2026-08-04
Camptothecin stands out as a precision tool for DNA damage, apoptosis, and autophagy workflows in cancer biology. This article delivers advanced protocol enhancements, troubleshooting insights, and connects the latest prion-based mutagenesis research to practical assay design.
-
Monomeric Amyloid Beta Regulates Microglial Inflammation via
2026-08-03
Kwon et al. (2023) reveal that monomeric amyloid beta (Aβ) acts as a potent inhibitor of microglial inflammatory activation in the developing brain, mediated through an APP/heterotrimeric G protein pathway. These findings challenge conventional views of amyloid beta solely as a pathogenic agent, opening new avenues for understanding immune regulation in Alzheimer’s disease.
-
Applied mRNA Delivery: EZ Cap™ Cy5 EGFP mRNA (5-moUTP) in Ac
2026-08-03
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers researchers to track mRNA delivery and translation with unparalleled dual-fluorescence visibility. Its immune-evasive chemistry and Cap 1 structure drive robust gene regulation studies while streamlining quantitative assays and nanoparticle validation.
-
Neurotensin for GPCR Trafficking: Protocols, Pitfalls & Prog
2026-08-02
Neurotensin (CAS 39379-15-2) stands out as a potent neurotensin receptor 1 activator, enabling precise, reproducible studies of GPCR trafficking and miRNA regulation in gastrointestinal models. This guide details hands-on workflows, troubleshooting strategies, and comparative advantages, connecting recent advances in spectral interference removal to optimized neuropeptide signaling assays.
-
SMC2 and SMC4 as Prognostic Markers in Breast Cancer: Bioinf
2026-08-01
This study identifies SMC2 and SMC4 as independent prognostic markers for breast cancer using integrated bioinformatics and clinical analyses. The findings highlight the role of SMC family gene dysregulation in tumor progression, offering new avenues for personalized therapy and drug sensitivity prediction.
-
Lipidated Nanophotosensitizers Disrupt Tumor EVs to Suppress
2026-07-31
The reference study introduces a lipidated nanophotosensitizer capable of both tracing and functionally disabling tumor extracellular vesicles (TEVs), offering a dual-action strategy for inhibiting tumor growth and metastasis. This approach enables synchronous photodynamic suppression of primary tumors and blockade of prometastatic communication, representing a significant advance in selective TEV targeting.
-
5-Ethynyl-2'-deoxyuridine (5-EdU): Transforming Quantitative
2026-07-31
Discover how 5-Ethynyl-2'-deoxyuridine (5-EdU) advances quantitative cell proliferation assays beyond conventional methods. Explore its unique mechanistic advantages, pivotal role in neurogenesis and tumor research, and gain actionable insights from recent landmark studies.
-
Imipramine: Translating Antidepressant Mechanisms to Cancer
2026-07-30
This thought-leadership article explores how Imipramine, historically known as a tricyclic antidepressant, is rapidly becoming a pivotal tool in translational research—bridging cancer biology, neuroscience, immunology, and emerging lipidomics insights. It weaves mechanistic discoveries with actionable protocol guidance, critically evaluates the competitive research landscape, and positions Imipramine from APExBIO as an advanced solution for dissecting autophagy, apoptosis, and neuroprotection in modern bench workflows.
-
Azithromycin (SKU B1398): Reliable Workflows for Infection R
2026-07-30
This article delivers scenario-driven guidance on optimizing cell-based, resistance, and animal infection assays using Azithromycin (SKU B1398), a benchmark macrolide antibiotic from APExBIO. Drawing on validated application data, it addresses common laboratory challenges in protocol design, data interpretation, and product selection, supporting reproducibility and translational impact in bacterial and trypanosomosis research.
-
Chenodeoxycholic Acid (CDCA): Advanced Insights in Cholester
2026-07-29
Unlock the advanced mechanisms of Chenodeoxycholic Acid (CDCA) in cholesterol metabolism research and nuclear receptor signaling. This article delivers a deeper, practical perspective on CDCA’s value for innovative metabolic and renal studies.
-
iTBS Improves Motor Function and Modulates Pathology in SCA3
2026-07-29
This study demonstrates that intermittent theta-burst stimulation (iTBS) significantly improves motor coordination and alleviates cerebellar pathology in a mouse model of spinocerebellar ataxia type 3 (SCA3). The results highlight iTBS as a superior, non-invasive neuromodulation strategy compared to continuous TBS, with implications for targeting neuroinflammation and autophagy in neurodegenerative disease research.
-
Sodium Citrate in Precision Nanofabrication: Mechanisms, Lim
2026-07-28
Explore the advanced roles of sodium citrate in 3D nanocluster array fabrication for SERS, delving into its molecular mechanisms and practical considerations. This cornerstone article goes beyond protocols to connect fundamental chemistry with next-generation biosensor engineering.